Navigation Links
Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
Date:9/24/2009

n a number of malignancies including colon cancer and is targeted for entry into clinical trials in 2012, fulfilling our goal of entering one new ACI into the clinic each year for the next three years.

About PROVENGE

PROVENGE is Dendreon's investigational product candidate for men with advanced prostate cancer and may represent the first in a new class of ACIs specifically designed to engage the patient's own immune system against cancer. PROVENGE and other ACIs are uniquely designed to use live human cells to engage the patient's own immune system with the goal of eliciting a specific long-lasting response against cancer. Dendreon recently announced that the pivotal Phase 3 IMPACT study of PROVENGE in men with advanced prostate cancer met its primary endpoint of improving overall survival compared to a placebo control.

Webcast Replay Information

If you are interested in listening to the replay of the analyst day webcast, you may access it from the Company's website at www.dendreon.com under the "Investor/Webcasts and Presentations" section.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce ACI product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington, and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit
'/>"/>

SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia
2. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
3. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
4. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
5. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
6. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
7. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
8. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
9. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
10. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
11. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 2015 DURECT Corporation (Nasdaq: DRRX ) ... three upcoming healthcare conferences.  , ... at the Rodman & Renshaw Investment Conference on Thursday, ... is being held at the St. Regis Hotel in ... audio webcast of the presentation will be available by ...
(Date:8/27/2015)...  Now that Intuitive Surgical, Inc.® has announced that ... hospitals with robotic surgery programs need to think about ... where they stand with robotic surgery. Are they performing ... adopted best practices for safety? Should they plan to ... ECRI Institute, which has nearly 50 years, experience ...
(Date:8/27/2015)... 2015   NineSigma the leading innovation partner to ... estimated overall revenue growth and anticipates the creation of over ... Open Innovation Incentive (OII). In 2013, the ... of over $2 million to accelerate adoption of open innovation ... and $1 Billion in revenues. To date over 45 middle ...
Breaking Medicine Technology:DURECT to Participate in Upcoming Healthcare Conferences 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3State of Ohio and NineSigma Collaborate to Drive Regional Economic Growth and Job Creation 2State of Ohio and NineSigma Collaborate to Drive Regional Economic Growth and Job Creation 3
(Date:8/28/2015)... ... ... Northridge dentists Dr. Elyson and Dr. Assili are now offering patients ... a one hour treatment of this teeth whitening option. Zoom whitening is ... features that can turn teeth up to nine shades whiter. Effective on a wide ...
(Date:8/28/2015)... ... August 28, 2015 , ... The ... distributing health information technology innovation to transform quality and efficiency of healthcare delivery ... will be de-identified and aggregated before being publicly shared to document progress and ...
(Date:8/28/2015)... ... August 28, 2015 , ... Popular ... 5 millionaire dating sites . According to the listings, MillionaireMatch.com ... in this category. , A spokesperson of Top5MillionaireDatingSites.com said, “This website ...
(Date:8/28/2015)... TN (PRWEB) , ... August 28, 2015 , ... A ... the Centers for Medicare & Medicaid Services’ (CMS) proposal to mandate bundled payments ... webinar , “Get Ready for Game Day: Comprehensive Care for Joint Replacement,” takes ...
(Date:8/28/2015)... ... August 28, 2015 , ... Where can successful, well educated, ... is set up to help quality singles find dating partners or ideal matches. ... rich, gorgeous, well educated, or attractive. , It updates profiles under the category ...
Breaking Medicine News(10 mins):Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2Health News:Top5MillionaireDatingSites.com Publishes Its First List of Reviews of the Best Millionaire Dating Sites 2Health News:PYA Offers Complimentary CCJR Webina — Game On 2Health News:PYA Offers Complimentary CCJR Webina — Game On 3Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 2Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 3
... the Journal of Sexual Medicine found that ... dysfunction constitutes a risk factor for a major cardiovascular ... often associated, and both are associated with an increased ... correlates further, researchers led by Elisa Bandini of the ...
... Louisville, KY. -- Hui Shao, MD, PhD, associate professor ... Louisville School of Medicine, has received a $60,000 Lew ... Blindness (RPB) organization. The grant will help fund Shao,s ... targets the salivary and lacrimal glands the glands ...
... Dotinga HealthDay Reporter , MONDAY, July 12 (HealthDay ... develops slower in people with bigger heads, perhaps because their ... not certain that head size, brain size and the rate ... research findings could pave the way for individualized treatment for ...
... Steven Reinberg HealthDay Reporter , MONDAY, July 12 ... and E might help keep our minds sharper, aid in ... disease, although much more research is needed to confirm the ... levels of vitamin D to higher odds of developing dementia, ...
... Mass. For the second year, Elke Rundensteiner, ... Institute (WPI), has been selected to participate in ... provides colleges, universities and research institutes around the ... with HP. WPI is one of only 52 ...
... patients aren,t walking talls Many of ... drugs that target dompamine, a chemical in the brain ... known as a neurotransmitter. However, such drugs do not ... individuals with severe and advanced forms of Parkinson disease. ...
Cached Medicine News:Health News:Shao wins grant from Research to Prevent Blindness organization for dry eye research 2Health News:Could Having a Bigger Head Help Slow Alzheimer's? 2Health News:Could Having a Bigger Head Help Slow Alzheimer's? 3Health News:Vitamins D, E Might Help Maintain Brain Health 2Health News:Vitamins D, E Might Help Maintain Brain Health 3Health News:Vitamins D, E Might Help Maintain Brain Health 4Health News:WPI computer science professor receives HP Labs Innovation Research Award 2Health News:WPI computer science professor receives HP Labs Innovation Research Award 3Health News:JCI online early table of contents: July 12, 2010 2Health News:JCI online early table of contents: July 12, 2010 3Health News:JCI online early table of contents: July 12, 2010 4Health News:JCI online early table of contents: July 12, 2010 5Health News:JCI online early table of contents: July 12, 2010 6Health News:JCI online early table of contents: July 12, 2010 7Health News:JCI online early table of contents: July 12, 2010 8
... ,AirSeps AirLife On-board Oxygen Concentrators were ... supplemental oxygen passengers and are still in ... the US governments FAA/STC approval for this ... commercial aircraft, AirSep set the standard years ...
... LifeStyle Portable Oxygen Concentrator is the most ... than 10 lbs (4.5 kg), this unit ... and highly active oxygen patient., ,Operating ... the technologies of both an oxygen concentrator ...
... up to 10 LPM of oxygen reducing the ... The M10 is engineered to reduce the cost ... has fewer parts than any other concentrator on ... help you to reduce expenditure on accessories and ...
... RCI oxygen conserving cannula ... prong" nose design and ... with standard connectors. This ... control and comfort in ...
Medicine Products: